Evidence map›Paper›PMID 38233647›Full record

ArticleNature microbiology2024

Gut commensal Christensenella minuta modulates host metabolism via acylated secondary bile acids.

Chang Liu, Meng-Xuan Du, Li-Sheng Xie, Wen-Zhao Wang, Bao-Song Chen, Chu-Yu Yun, Xin-Wei Sun, Xi Luo, Yu Jiang, Kai Wang and 12 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
26.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 93 citations in OpenAlex.

  1. Trial
  2. Gut microbes · 2026
    Article
  3. Expanding bile acid diversityNatural product reports · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 1 country.

Chang Liu *State Key Laboratory of Microbial Technology, Shandong University, Qingdao, P. R. China.ORCID http://orcid.org/0000-0001-9398-3701
Meng-Xuan Du *State Key Laboratory of Microbial Technology, Shandong University, Qingdao, P. R. China.
Li-Sheng Xie *College of Life Science, Hebei University, Baoding, P. R. China.
Wen-Zhao WangState Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P. R. China.
Bao-Song ChenState Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P. R. China.
Chu-Yu YunDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P. R. China.
Xin-Wei SunState Key Laboratory of Microbial Technology, Shandong University, Qingdao, P. R. China.
Xi LuoDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P. R. China.
Yu JiangState Key Laboratory of Microbial Technology, Shandong University, Qingdao, P. R. China.
Kai WangDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P. R. China.ORCID http://orcid.org/0000-0001-9705-6366
Min-Zhi JiangState Key Laboratory of Microbial Technology, Shandong University, Qingdao, P. R. China.
Shan-Shan QiaoState Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P. R. China.
Min SunThe Second Hospital of Shandong University, Jinan, P. R. China.
Bao-Juan CuiThe Second Hospital of Shandong University, Jinan, P. R. China.
Hao-Jie HuangState Key Laboratory of Microbial Technology, Shandong University, Qingdao, P. R. China.ORCID http://orcid.org/0000-0001-6546-3741
Shu-Ping QuShimadzu (China) Co, Beijing, P. R. China.
Chang-Kun LiShimadzu (China) Co, Beijing, P. R. China.
Dalei WuState Key Laboratory of Microbial Technology, Shandong University, Qingdao, P. R. China.ORCID http://orcid.org/0000-0003-1817-7229
Lu-Shan WangState Key Laboratory of Microbial Technology, Shandong University, Qingdao, P. R. China.
Changtao JiangDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, P. R. China. jiangchangtao@bjmu.edu.cn.ORCID http://orcid.org/0000-0002-5206-2372
Hong-Wei LiuState Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P. R. China. liuhw@im.ac.cn.ORCID http://orcid.org/0000-0001-6471-131X
Shuang-Jiang LiuState Key Laboratory of Microbial Technology, Shandong University, Qingdao, P. R. China. liusj@im.ac.cn.ORCID http://orcid.org/0000-0002-7585-310X
Shandong University · CNChinese Academy of Sciences · CNPeking University · CNSecond Hospital of Shandong University · CNShimadzu (China) · CNHebei University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A strong correlation between gut microbes and host health has been observed in numerous gut metagenomic cohort studies. However, the underlying mechanisms governing host-microbe interactions in the gut remain largely unknown. Here we report that the gut commensal Christensenella minuta modulates host metabolism by generating a previously undescribed class of secondary bile acids with 3-O-acylation substitution that inhibit the intestinal farnesoid X receptor. Administration of C. minuta alleviated features of metabolic disease in high fat diet-induced obese mice associated with a significant increase in these acylated bile acids, which we refer to as 3-O-acyl-cholic acids. Specific knockout of intestinal farnesoid X receptor in mice counteracted the beneficial effects observed in their wild-type counterparts. Finally, we showed that 3-O-acyl-CAs were prevalent in healthy humans but significantly depleted in patients with type 2 diabetes. Our findings indicate a role for C. minuta and acylated bile acids in metabolic diseases.

Indexed as

Bile Acids and SaltsDiabetes Mellitus, Type 2AnimalsDiet, High-FatEubacterialesHumansMiceBile Acids and Salts

Identifiers

PMID38233647
OpenAlexW4390947551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.